Scientists from the U.S. National Institutes of Health found a link between dozens of different viral exposures and a later increased risk of Alzheimer’s disease and other brain disorders. Gizmodo reports: They analyzed data from two existing and natio…

Amazon said on Tuesday it is offering a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic drugs and their doorstep delivery, furthering the ecommerce giant’s push into healthcare. From a report: The program, named R…

An anonymous reader quotes a report from Ars Technica: According to a new study, a little over 70 percent of prescription drugs advertised on television were rated as having “low therapeutic value,” meaning they offer little benefit compared with drugs…

An anonymous reader writes: The pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when [FDA] advisers discussed whether the shot should be authorized and made available…

“When Robert Wood came to Harvard University 17 years ago, he wanted to design an insect-sized robot that could fly,” reports the Boston Globe. And finally Last month, technology from Wood’s “RoboBee” project was commercialized for the first time, “spi…

The rate of people dying from cancer in the United States has continuously declined over the past three decades, according to a new report from the American Cancer Society. CNN reports: The US cancer death rate has fallen 33% since 1991, which correspo…

New medicines need not be tested in animals to receive U.S. Food and Drug Administration (FDA) approval, according to legislation signed by President Joe Biden in late December 2022. Science Magazine reports: “This is huge,” says Tamara Drake, director…

“To date, about 500 people have been put in cryogenic stasis after legal death,” writes a Bloomberg Opinion technology columnist, “with the majority of them in the U.S.

“But a few thousand more, including Emil Kendziorra, are on waiting lists, wearin…

The Food and Drug Administration on Friday approved a new Alzheimer’s drug that may modestly slow the pace of cognitive decline early in the disease, but also carries risks of swelling and bleeding in the brain. From a report: The approval of the drug,…

An anonymous reader quotes a report from The Register: Askern Medical Practice, a general practitioner surgery based in Doncaster, UK, managed to muddle its Christmas holiday message to patients by texting them they’d been diagnosed with “aggressive lu…